US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Protalix BioTherapeutics

1.86

-0.5400-22.50%

Post-market: 1.870.0105+0.56%19:56 EDT

Volume:5.51M

Turnover:9.61M

Market Cap:148.30M

PE:24.02

High:1.90

Open:1.68

Low:1.60

Close:2.40

52wk High:3.10

52wk Low:1.01

Shares:79.73M

Float Shares:60.76M

Volume Ratio:6.67

T/O Rate:9.07%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.0774

EPS(LYR):0.0404

ROE:15.99%

ROA:6.05%

PB:2.97

PE(LYR):46.01

Loading ...

Overview Company News Filings

Why Is Protalix BioTherapeutics Stock Falling On Friday?

Benzinga_recent_news

Protalix Shares Sink After EMA Rejects Once-Monthly Treatment Plan

Protalix BioTherapeutics Highlights Rare Disease Drug Pipeline and New Gout Therapy in Latest Corporate Presentation

Barclays Remains a Hold on PLUXEE N.V. (PLX)

3 Penny Stocks With Market Caps Over $30M To Consider

Simply Wall St.

PLUXEE N.V. (PLX) was downgraded to a Hold Rating at Bernstein

Protalix BioTherapeutics Inc. to Present at the Upcoming Investor Summit Virtual Event

Protalix BioTherapeutics Inc. to Present at H.C. Wainwright 27th Annual Global Investment Conference in New York City

Protalix BioTherapeutics Inc. Releases Presentation Highlighting Expansion into Rare Disease Space and Commercialization of Elfabrio®

Protalix BioTherapeutics Inc. Files Initial Beneficial Ownership Statement for Gilad Mamlok, Sr. VP and CFO

Protalix BioTherapeutics Q2 Sales $15.658M Beat $13.546M Estimate

Protalix BioTherapeutics Reports 16% Revenue Increase in Q2 2025, Achieves Net Income of $164K, EPS at $0.00

Director Aharon Schwartz Reports Acquisition of Protalix BioTherapeutics Common Shares

Protalix BioTherapeutics Inc. to Release Second Quarter 2025 Financial Results

Protalix BioTherapeutics Appoints Gilad Mamlok as New CFO, Succeeding Eyal Rubin

Protalix BioTherapeutics Inc. Files Initial Statement of Beneficial Ownership for Director Elze Christian

Protalix BioTherapeutics Joins Russell 3000 and 2000 Indexes

Protalix BioTherapeutics Inc. Convened Annual Stockholders Meeting

Protalix BioTherapeutics Inc. Unveils Corporate Presentation Highlighting Expansion in Rare Disease Space

Protalix BioTherapeutics Inc. to Present at H.C. Wainwright BioConnect Investor Conference in NYC

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/PLX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PLX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PLX\",,,,,undefined,":{"symbol":"PLX","market":"US","secType":"STK","nameCN":"Protalix BioTherapeutics","latestPrice":1.86,"timestamp":1760731200000,"preClose":2.4,"halted":0,"volume":5510116,"hourTrading":{"tag":"盘后","latestPrice":1.8705,"preClose":1.86,"latestTime":"19:56 EDT","volume":15530,"amount":28892.5392,"timestamp":1760745412906},"delay":0,"floatShares":60755281,"shares":79732115,"eps":0.07744,"marketStatus":"Market Closed","change":-0.54,"latestTime":"10-17 16:00:00 EDT","open":1.68,"high":1.9,"low":1.6,"amount":9611894.2884092,"amplitude":0.125,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":0.07744,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1760947200000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":829022400000,"exchange":"AMEX","adjPreClose":2.4,"preHourTrading":{"tag":"盘前","latestPrice":1.6751,"preClose":2.4,"latestTime":"09:29 EDT","volume":184579,"amount":334863.5540422,"timestamp":1760707796549},"postHourTrading":{"tag":"盘后","latestPrice":1.8705,"preClose":1.86,"latestTime":"19:56 EDT","volume":15530,"amount":28892.5392,"timestamp":1760745412906},"volumeRatio":6.671554183686447,"impliedVol":0.446,"impliedVolPercentile":0.22},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PLX\",,,,,undefined,":{"symbol":"PLX","floatShares":60755281,"roa":"6.05%","roe":"15.99%","lyrEps":0.040424,"volumeRatio":6.671554183686447,"shares":79732115,"dividePrice":0,"high":1.9,"amplitude":0.125,"preClose":2.4,"low":1.6,"week52Low":1.01,"pbRate":"2.97","psRate":"2.39","week52High":3.1,"institutionHeld":0.2614,"latestPrice":1.86,"eps":0.07744,"divideRate":0,"volume":5510116,"delay":0,"ttmEps":0.07744,"open":1.68,"prevYearClose":1.88,"prevWeekClose":2.36,"prevMonthClose":2.22,"prevQuarterClose":2.22,"fiveDayClose":2.36,"twentyDayClose":1.89,"sixtyDayClose":1.55},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PLX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-14","symbol":"PLX","fiscalQuarterEnding":"2025/06","expectedEps":0.03,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"pre","actualEps":0},{"market":"US","date":"2025-05-09","symbol":"PLX","fiscalQuarterEnding":"2025/03","expectedEps":0.08,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746763200000,"reportTimeType":"pre","actualEps":-0.05},{"market":"US","date":"2025-03-17","symbol":"PLX","fiscalQuarterEnding":"2024/12","expectedEps":0.07,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1742184000000,"reportTimeType":"pre","actualEps":0.09},{"market":"US","date":"2024-11-14","symbol":"PLX","fiscalQuarterEnding":"2024/09","expectedEps":0.06,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"pre","actualEps":0.03},{"market":"US","date":"2024-08-14","symbol":"PLX","fiscalQuarterEnding":"2024/06","expectedEps":0.02,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723608000000,"reportTimeType":"pre","actualEps":-0.03}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PLX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PLX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1738728000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PLX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PLX","date":"2025-10-17","current":24.018595,"percent":0.930838,"low":-43.274752,"twenty":-9.762245,"median":-2.772018,"eighty":11.990948,"high":81.705333,"avg":0.746184,"sd":19.110929,"marketCap":191357076},"quantilePoints":[{"date":"2020-10-23","current":-19.910032,"twenty":-3.109096,"median":-2.159816,"eighty":-1.286168,"marketCap":114522505},{"date":"2020-10-30","current":-16.444568,"twenty":-3.109096,"median":-2.159816,"eighty":-1.286168,"marketCap":109011038},{"date":"2020-11-06","current":-16.243411,"twenty":-3.109096,"median":-2.159816,"eighty":-1.286168,"marketCap":107677570},{"date":"2020-11-13","current":-17.148616,"twenty":-3.133674,"median":-2.159816,"eighty":-1.286168,"marketCap":113678177},{"date":"2020-11-20","current":-19.914522,"twenty":-3.195119,"median":-2.159816,"eighty":-1.286168,"marketCap":132013367},{"date":"2020-11-27","current":-18.204689,"twenty":-3.23072,"median":-2.159816,"eighty":-1.286168,"marketCap":120678886},{"date":"2020-12-04","current":-17.136276,"twenty":-3.35334,"median":-2.159816,"eighty":-1.286168,"marketCap":113596373},{"date":"2020-12-11","current":-18.121119,"twenty":-3.873376,"median":-2.159816,"eighty":-1.286168,"marketCap":120124900},{"date":"2020-12-18","current":-17.333245,"twenty":-4.1371,"median":-2.159816,"eighty":-1.286168,"marketCap":114902078},{"date":"2020-12-24","current":-16.939307,"twenty":-4.175152,"median":-2.159816,"eighty":-1.286168,"marketCap":112290667},{"date":"2020-12-31","current":-17.874908,"twenty":-4.217317,"median":-2.159816,"eighty":-1.286168,"marketCap":118492768},{"date":"2021-01-08","current":-18.318088,"twenty":-4.444705,"median":-2.159816,"eighty":-1.286168,"marketCap":121430605},{"date":"2021-01-15","current":-20.533986,"twenty":-4.900297,"median":-2.159816,"eighty":-1.286168,"marketCap":136119792},{"date":"2021-01-22","current":-22.552915,"twenty":-5.019257,"median":-2.159816,"eighty":-1.286168,"marketCap":149503272},{"date":"2021-01-29","current":-21.568071,"twenty":-5.289946,"median":-2.159816,"eighty":-1.286168,"marketCap":142974745},{"date":"2021-02-05","current":-24.177906,"twenty":-5.314856,"median":-2.159816,"eighty":-1.286168,"marketCap":160275342},{"date":"2021-02-12","current":-32.70229,"twenty":-5.396455,"median":-2.159816,"eighty":-1.286168,"marketCap":216783482},{"date":"2021-02-19","current":-34.103817,"twenty":-5.467461,"median":-2.159816,"eighty":-1.286168,"marketCap":226074202},{"date":"2021-02-26","current":-33.545915,"twenty":-5.52745,"median":-2.159816,"eighty":-1.286168,"marketCap":222375871},{"date":"2021-03-05","current":-28.68518,"twenty":-5.574564,"median":-2.158792,"eighty":-1.286095,"marketCap":190154061},{"date":"2021-03-12","current":-33.20361,"twenty":-5.648785,"median":-2.158792,"eighty":-1.286095,"marketCap":220106730},{"date":"2021-03-19","current":-34.915136,"twenty":-5.812013,"median":-2.158792,"eighty":-1.286095,"marketCap":231452438},{"date":"2021-03-26","current":-33.066688,"twenty":-5.93244,"median":-2.159816,"eighty":-1.286168,"marketCap":219199073},{"date":"2021-04-01","current":-31.238527,"twenty":-6.011792,"median":-2.159816,"eighty":-1.286168,"marketCap":203768911},{"date":"2021-04-09","current":-36.595691,"twenty":-6.161232,"median":-2.158792,"eighty":-1.286095,"marketCap":238713691},{"date":"2021-04-16","current":-43.135605,"twenty":-6.301781,"median":-2.158792,"eighty":-1.286095,"marketCap":281373552},{"date":"2021-04-23","current":-43.274752,"twenty":-6.484124,"median":-2.158792,"eighty":-1.286095,"marketCap":282281208},{"date":"2021-04-30","current":-23.307141,"twenty":-6.640471,"median":-2.159816,"eighty":-1.286168,"marketCap":152032483},{"date":"2021-05-07","current":-21.150361,"twenty":-6.746429,"median":-2.159816,"eighty":-1.286168,"marketCap":137963806},{"date":"2021-05-14","current":-9.099814,"twenty":-6.956439,"median":-2.159816,"eighty":-1.286168,"marketCap":124348956},{"date":"2021-05-21","current":-9.664401,"twenty":-7.610873,"median":-2.159816,"eighty":-1.286168,"marketCap":132064038},{"date":"2021-05-28","current":-10.096144,"twenty":-9.073245,"median":-2.159816,"eighty":-1.286168,"marketCap":137963806},{"date":"2021-06-04","current":-7.107154,"twenty":-9.166236,"median":-2.159816,"eighty":-1.286168,"marketCap":97119258},{"date":"2021-06-11","current":-7.206787,"twenty":-9.166236,"median":-2.159816,"eighty":-1.286168,"marketCap":98480743},{"date":"2021-06-18","current":-6.6422,"twenty":-9.166236,"median":-2.159816,"eighty":-1.286168,"marketCap":90765662},{"date":"2021-06-25","current":-6.608989,"twenty":-9.099814,"median":-2.160476,"eighty":-1.286241,"marketCap":90311833},{"date":"2021-07-02","current":-5.97798,"twenty":-9.099814,"median":-2.160476,"eighty":-1.286241,"marketCap":81689095},{"date":"2021-07-09","current":-5.745503,"twenty":-9.099814,"median":-2.160476,"eighty":-1.286241,"marketCap":78512297},{"date":"2021-07-16","current":-5.247338,"twenty":-9.099814,"median":-2.160476,"eighty":-1.286241,"marketCap":71704872},{"date":"2021-07-23","current":-5.214127,"twenty":-9.099814,"median":-2.160476,"eighty":-1.286241,"marketCap":71251044},{"date":"2021-07-30","current":-5.014861,"twenty":-9.099814,"median":-2.160476,"eighty":-1.286241,"marketCap":68528074},{"date":"2021-08-06","current":-4.98165,"twenty":-9.099814,"median":-2.160476,"eighty":-1.286241,"marketCap":68074246},{"date":"2021-08-13","current":-4.450274,"twenty":-9.099814,"median":-2.160476,"eighty":-1.286241,"marketCap":60812993},{"date":"2021-08-20","current":-2.941121,"twenty":-9.099814,"median":-2.160476,"eighty":-1.286241,"marketCap":61045906},{"date":"2021-08-27","current":-3.511786,"twenty":-9.099814,"median":-2.160476,"eighty":-1.286241,"marketCap":72890635},{"date":"2021-09-03","current":-3.533735,"twenty":-9.093172,"median":-2.165862,"eighty":-1.286241,"marketCap":73346201},{"date":"2021-09-10","current":-3.2923,"twenty":-9.093172,"median":-2.168414,"eighty":-1.286241,"marketCap":68334970},{"date":"2021-09-17","current":-3.072813,"twenty":-9.093172,"median":-2.169861,"eighty":-1.286241,"marketCap":63779305},{"date":"2021-09-24","current":-2.875275,"twenty":-9.093172,"median":-2.173457,"eighty":-1.286241,"marketCap":59679207},{"date":"2021-10-01","current":-2.743583,"twenty":-9.093172,"median":-2.185224,"eighty":-1.286241,"marketCap":56945808},{"date":"2021-10-08","current":-2.919172,"twenty":-9.08653,"median":-2.194729,"eighty":-1.286241,"marketCap":60590340},{"date":"2021-10-15","current":-2.699686,"twenty":-9.08653,"median":-2.198569,"eighty":-1.286241,"marketCap":56034675},{"date":"2021-10-22","current":-2.546045,"twenty":-9.08653,"median":-2.208245,"eighty":-1.286241,"marketCap":52845710},{"date":"2021-10-29","current":-2.480199,"twenty":-9.08653,"median":-2.213276,"eighty":-1.286241,"marketCap":51479011},{"date":"2021-11-05","current":-2.436302,"twenty":-9.08653,"median":-2.224699,"eighty":-1.286241,"marketCap":50567878},{"date":"2021-11-12","current":-2.502148,"twenty":-9.08653,"median":-2.237881,"eighty":-1.286241,"marketCap":51934577},{"date":"2021-11-19","current":-2.175919,"twenty":-9.08653,"median":-2.240695,"eighty":-1.286241,"marketCap":44645514},{"date":"2021-11-26","current":-2.198123,"twenty":-9.08653,"median":-2.240695,"eighty":-1.286241,"marketCap":45101080},{"date":"2021-12-03","current":-1.806013,"twenty":-9.08653,"median":-2.233869,"eighty":-1.286241,"marketCap":37055776},{"date":"2021-12-10","current":-2.038925,"twenty":-9.079887,"median":-2.232086,"eighty":-1.286241,"marketCap":41834668},{"date":"2021-12-17","current":-1.940121,"twenty":-9.079887,"median":-2.232086,"eighty":-1.286241,"marketCap":39807398},{"date":"2021-12-23","current":-2.10931,"twenty":-9.079887,"median":-2.232086,"eighty":-1.286241,"marketCap":43278814},{"date":"2021-12-31","current":-1.846645,"twenty":-9.079887,"median":-2.228368,"eighty":-1.286241,"marketCap":37889463},{"date":"2022-01-07","current":-1.90948,"twenty":-9.073245,"median":-2.222793,"eighty":-1.286241,"marketCap":39178716},{"date":"2022-01-14","current":-1.909036,"twenty":-9.073245,"median":-2.219151,"eighty":-1.286241,"marketCap":39169605},{"date":"2022-01-21","current":-1.809011,"twenty":-9.073245,"median":-2.213239,"eighty":-1.286241,"marketCap":37117278},{"date":"2022-01-28","current":-1.800151,"twenty":-9.073245,"median":-2.199659,"eighty":-1.286241,"marketCap":36935507},{"date":"2022-02-04","current":-2.286936,"twenty":-9.073245,"median":-2.19473,"eighty":-1.286241,"marketCap":46923346},{"date":"2022-02-11","current":-2.053801,"twenty":-9.073245,"median":-2.192317,"eighty":-1.286241,"marketCap":42139898},{"date":"2022-02-18","current":-1.900155,"twenty":-9.073245,"median":-2.182859,"eighty":-1.286241,"marketCap":38987378},{"date":"2022-02-25","current":-1.845979,"twenty":-9.073245,"median":-2.171729,"eighty":-1.286241,"marketCap":37875796},{"date":"2022-03-04","current":-1.953887,"twenty":-9.073245,"median":-2.164775,"eighty":-1.286241,"marketCap":40089849},{"date":"2022-03-11","current":-1.931683,"twenty":-9.073245,"median":-2.149114,"eighty":-1.286241,"marketCap":39634282},{"date":"2022-03-18","current":-2.331342,"twenty":-9.073245,"median":-2.134081,"eighty":-1.286241,"marketCap":47834479},{"date":"2022-03-25","current":-2.58668,"twenty":-9.073245,"median":-2.134081,"eighty":-1.286241,"marketCap":53073493},{"date":"2022-04-01","current":-1.763177,"twenty":-9.073245,"median":-2.127387,"eighty":-1.286241,"marketCap":48631935},{"date":"2022-04-08","current":-2.518824,"twenty":-9.073245,"median":-2.127387,"eighty":-1.286241,"marketCap":69474193},{"date":"2022-04-14","current":-2.199773,"twenty":-9.073245,"median":-2.127387,"eighty":-1.286241,"marketCap":60674128},{"date":"2022-04-22","current":-2.000411,"twenty":-9.073245,"median":-2.122964,"eighty":-1.286241,"marketCap":55175340},{"date":"2022-04-29","current":-1.950023,"twenty":-9.073245,"median":-2.109577,"eighty":-1.286241,"marketCap":53785525},{"date":"2022-05-06","current":-1.907996,"twenty":-9.073245,"median":-2.106167,"eighty":-1.286241,"marketCap":52626354},{"date":"2022-05-13","current":-1.781917,"twenty":-9.073245,"median":-2.101634,"eighty":-1.296523,"marketCap":49148841},{"date":"2022-05-20","current":-2.19949,"twenty":-9.073245,"median":-2.104124,"eighty":-1.305734,"marketCap":53652162},{"date":"2022-05-27","current":-2.19949,"twenty":-9.073245,"median":-2.108744,"eighty":-1.316067,"marketCap":53652162},{"date":"2022-06-03","current":-2.392428,"twenty":-9.073245,"median":-2.111908,"eighty":-1.325755,"marketCap":58358492},{"date":"2022-06-10","current":-2.160903,"twenty":-9.073245,"median":-2.122315,"eighty":-1.336668,"marketCap":52710896},{"date":"2022-06-17","current":-2.103021,"twenty":-9.073245,"median":-2.122315,"eighty":-1.340638,"marketCap":51298997},{"date":"2022-06-24","current":-2.103021,"twenty":-9.079887,"median":-2.122315,"eighty":-1.345105,"marketCap":51298997},{"date":"2022-07-01","current":-2.093374,"twenty":-9.079887,"median":-2.123693,"eighty":-1.358968,"marketCap":51063680},{"date":"2022-07-08","current":-2.141609,"twenty":-9.079887,"median":-2.128772,"eighty":-1.362564,"marketCap":52240263},{"date":"2022-07-15","current":-2.083727,"twenty":-9.079887,"median":-2.129233,"eighty":-1.365604,"marketCap":50828364},{"date":"2022-07-22","current":-2.04514,"twenty":-9.079887,"median":-2.129233,"eighty":-1.382433,"marketCap":49887098},{"date":"2022-07-29","current":-2.04514,"twenty":-9.079887,"median":-2.129233,"eighty":-1.400792,"marketCap":49887098},{"date":"2022-08-05","current":-2.122315,"twenty":-9.079887,"median":-2.129233,"eighty":-1.416087,"marketCap":51769630},{"date":"2022-08-12","current":-2.363487,"twenty":-9.079887,"median":-2.141609,"eighty":-1.428705,"marketCap":57652542},{"date":"2022-08-19","current":-3.229692,"twenty":-9.079887,"median":-2.151454,"eighty":-1.454072,"marketCap":59704090},{"date":"2022-08-26","current":-3.175864,"twenty":-9.079887,"median":-2.160903,"eighty":-1.46638,"marketCap":58709022},{"date":"2022-09-02","current":-2.933637,"twenty":-9.079887,"median":-2.168513,"eighty":-1.513357,"marketCap":54231215},{"date":"2022-09-09","current":-2.866352,"twenty":-9.079887,"median":-2.173457,"eighty":-1.552879,"marketCap":52987380},{"date":"2022-09-16","current":-3.068208,"twenty":-9.079887,"median":-2.185224,"eighty":-1.597561,"marketCap":56718886},{"date":"2022-09-23","current":-2.772152,"twenty":-9.079887,"median":-2.19473,"eighty":-1.642895,"marketCap":51246011},{"date":"2022-09-30","current":-2.802835,"twenty":-9.079887,"median":-2.19949,"eighty":-1.691667,"marketCap":51813200},{"date":"2022-10-07","current":-2.799067,"twenty":-9.079887,"median":-2.205652,"eighty":-1.708303,"marketCap":51743545},{"date":"2022-10-14","current":-2.745238,"twenty":-9.079887,"median":-2.213275,"eighty":-1.720523,"marketCap":50748477},{"date":"2022-10-21","current":-2.772152,"twenty":-9.079887,"median":-2.225261,"eighty":-1.725838,"marketCap":51246011},{"date":"2022-10-28","current":-2.772152,"twenty":-9.079887,"median":-2.240109,"eighty":-1.732273,"marketCap":51246011},{"date":"2022-11-04","current":-2.718324,"twenty":-9.079887,"median":-2.242805,"eighty":-1.755663,"marketCap":50250943},{"date":"2022-11-11","current":-2.825981,"twenty":-9.079887,"median":-2.250369,"eighty":-1.765675,"marketCap":52241079},{"date":"2022-11-18","current":-3.036417,"twenty":-9.079887,"median":-2.262195,"eighty":-1.778799,"marketCap":54212189},{"date":"2022-11-25","current":-3.391139,"twenty":-9.079887,"median":-2.26358,"eighty":-1.789218,"marketCap":60545389},{"date":"2022-12-02","current":-3.206683,"twenty":-9.079887,"median":-2.278354,"eighty":-1.795365,"marketCap":57252125},{"date":"2022-12-09","current":-3.320194,"twenty":-9.079887,"median":-2.292748,"eighty":-1.799662,"marketCap":59278749},{"date":"2022-12-16","current":-3.291817,"twenty":-9.079887,"median":-2.300018,"eighty":-1.807377,"marketCap":58772093},{"date":"2022-12-23","current":-3.348572,"twenty":-9.079887,"median":-2.308362,"eighty":-1.815181,"marketCap":59785405},{"date":"2022-12-30","current":-3.887749,"twenty":-9.079887,"median":-2.330304,"eighty":-1.816065,"marketCap":69411869},{"date":"2023-01-06","current":-4.341793,"twenty":-9.079887,"median":-2.331425,"eighty":-1.819992,"marketCap":77518364},{"date":"2023-01-13","current":-4.597192,"twenty":-9.079887,"median":-2.347715,"eighty":-1.827125,"marketCap":82078268},{"date":"2023-01-20","current":-4.739081,"twenty":-9.079887,"median":-2.35453,"eighty":-1.836965,"marketCap":84611548},{"date":"2023-01-27","current":-4.455303,"twenty":-9.079887,"median":-2.366765,"eighty":-1.846672,"marketCap":79544988},{"date":"2023-02-03","current":-4.597192,"twenty":-9.079887,"median":-2.372929,"eighty":-1.855292,"marketCap":82078268},{"date":"2023-02-10","current":-4.483681,"twenty":-9.079887,"median":-2.377975,"eighty":-1.863262,"marketCap":80051644},{"date":"2023-02-17","current":-4.426926,"twenty":-9.079887,"median":-2.386937,"eighty":-1.865474,"marketCap":79038332},{"date":"2023-02-24","current":-5.164747,"twenty":-9.079887,"median":-2.395361,"eighty":-1.8693,"marketCap":92211388},{"date":"2023-03-03","current":-7.880419,"twenty":-9.079887,"median":-2.409349,"eighty":-1.87939,"marketCap":117631009},{"date":"2023-03-10","current":-7.111597,"twenty":-9.079887,"median":-2.414353,"eighty":-1.887277,"marketCap":106154813},{"date":"2023-03-17","current":-7.803536,"twenty":-9.079887,"median":-2.420155,"eighty":-1.897474,"marketCap":116483389},{"date":"2023-03-24","current":-7.649772,"twenty":-9.079887,"median":-2.433443,"eighty":-1.901141,"marketCap":114188150},{"date":"2023-03-31","current":-8.072624,"twenty":-9.073245,"median":-2.439918,"eighty":-1.90865,"marketCap":120500058},{"date":"2023-04-06","current":-8.226388,"twenty":-9.073245,"median":-2.446146,"eighty":-1.912148,"marketCap":122795297},{"date":"2023-04-14","current":-9.571826,"twenty":-9.400542,"median":-2.46771,"eighty":-1.922938,"marketCap":142878640},{"date":"2023-04-21","current":-8.956768,"twenty":-9.457132,"median":-2.480199,"eighty":-1.931683,"marketCap":133697683},{"date":"2023-04-28","current":-10.263765,"twenty":-9.567591,"median":-2.502031,"eighty":-1.934828,"marketCap":153207216},{"date":"2023-05-05","current":-14.724601,"twenty":-9.651117,"median":-2.520118,"eighty":-1.939455,"marketCap":219794121},{"date":"2023-05-12","current":-10.576213,"twenty":-10.196717,"median":-2.536056,"eighty":-1.94368,"marketCap":166808038},{"date":"2023-05-19","current":-9.162809,"twenty":-10.196717,"median":-2.545576,"eighty":-1.945022,"marketCap":144515819},{"date":"2023-05-26","current":-8.948724,"twenty":-10.196717,"median":-2.560684,"eighty":-1.945022,"marketCap":141139282},{"date":"2023-06-02","current":-9.162809,"twenty":-10.196717,"median":-2.582062,"eighty":-1.945022,"marketCap":144515819},{"date":"2023-06-09","current":-9.976329,"twenty":-10.332959,"median":-2.61351,"eighty":-1.945022,"marketCap":157346663},{"date":"2023-06-16","current":-9.633794,"twenty":-10.332959,"median":-2.630673,"eighty":-1.945022,"marketCap":151944203},{"date":"2023-06-23","current":-9.505344,"twenty":-10.356023,"median":-2.656774,"eighty":-1.945022,"marketCap":149918280},{"date":"2023-06-30","current":-9.291259,"twenty":-10.379088,"median":-2.691448,"eighty":-1.945022,"marketCap":146541742},{"date":"2023-07-07","current":-7.664219,"twenty":-10.379088,"median":-2.708789,"eighty":-1.945022,"marketCap":120880055},{"date":"2023-07-14","current":-7.664219,"twenty":-10.379088,"median":-2.729688,"eighty":-1.945022,"marketCap":120880055},{"date":"2023-07-21","current":-7.364501,"twenty":-10.379088,"median":-2.745103,"eighty":-1.945022,"marketCap":116152902},{"date":"2023-07-28","current":-7.150416,"twenty":-10.379088,"median":-2.745238,"eighty":-1.945022,"marketCap":112776364},{"date":"2023-08-04","current":-7.364501,"twenty":-10.38417,"median":-2.755336,"eighty":-1.944575,"marketCap":116152902},{"date":"2023-08-11","current":15.199151,"twenty":-10.38417,"median":-2.755336,"eighty":-1.94037,"marketCap":135287640},{"date":"2023-08-18","current":15.359988,"twenty":-10.38417,"median":-2.755336,"eighty":-1.94037,"marketCap":136719255},{"date":"2023-08-25","current":16.244595,"twenty":-10.38417,"median":-2.755336,"eighty":-1.94037,"marketCap":144593139},{"date":"2023-09-01","current":15.199151,"twenty":-10.38417,"median":-2.755336,"eighty":-1.94037,"marketCap":135287640},{"date":"2023-09-08","current":14.797057,"twenty":-10.38417,"median":-2.755336,"eighty":-1.94037,"marketCap":131708602},{"date":"2023-09-15","current":13.91245,"twenty":-10.38417,"median":-2.755336,"eighty":-1.94037,"marketCap":123834718},{"date":"2023-09-22","current":13.349518,"twenty":-10.38417,"median":-2.755336,"eighty":-1.937003,"marketCap":118824064},{"date":"2023-09-29","current":12.947425,"twenty":-10.38417,"median":-2.755336,"eighty":-1.931683,"marketCap":115245026},{"date":"2023-10-06","current":12.867006,"twenty":-10.38417,"median":-2.74793,"eighty":-1.924528,"marketCap":114529219},{"date":"2023-10-13","current":11.982399,"twenty":-10.38417,"median":-2.74793,"eighty":-1.91452,"marketCap":106655335},{"date":"2023-10-20","current":11.741143,"twenty":-10.38417,"median":-2.74793,"eighty":-1.909391,"marketCap":104507912},{"date":"2023-10-27","current":11.982399,"twenty":-10.399416,"median":-2.764616,"eighty":-1.90816,"marketCap":106655335},{"date":"2023-11-03","current":13.590775,"twenty":-10.399416,"median":-2.764616,"eighty":-1.90816,"marketCap":120971487},{"date":"2023-11-10","current":9.551945,"twenty":-10.399416,"median":-2.764616,"eighty":-1.899704,"marketCap":101403452},{"date":"2023-11-17","current":9.551945,"twenty":-10.399416,"median":-2.764616,"eighty":-1.899275,"marketCap":101403452},{"date":"2023-11-24","current":9.826821,"twenty":-10.399416,"median":-2.764616,"eighty":-1.899275,"marketCap":104321537},{"date":"2023-12-01","current":10.376574,"twenty":-10.399416,"median":-2.764616,"eighty":-1.899275,"marketCap":110157707},{"date":"2023-12-08","current":11.682235,"twenty":-10.394334,"median":-2.758695,"eighty":-1.898511,"marketCap":124018610},{"date":"2023-12-15","current":12.09455,"twenty":-10.394334,"median":-2.758695,"eighty":-1.898511,"marketCap":128395738},{"date":"2023-12-22","current":11.957111,"twenty":-10.394334,"median":-2.758695,"eighty":-1.898511,"marketCap":126936695},{"date":"2023-12-29","current":12.369426,"twenty":-10.399416,"median":-2.764616,"eighty":-1.899275,"marketCap":131313823},{"date":"2024-01-05","current":11.957111,"twenty":-10.404498,"median":-2.770538,"eighty":-1.89955,"marketCap":126936695},{"date":"2024-01-12","current":11.269921,"twenty":-10.404498,"median":-2.770538,"eighty":-1.89955,"marketCap":119641483},{"date":"2024-01-19","current":10.101698,"twenty":-10.438841,"median":-2.771211,"eighty":-1.899583,"marketCap":107239622},{"date":"2024-01-26","current":10.376574,"twenty":-10.404498,"median":-2.770538,"eighty":-1.898048,"marketCap":110157707},{"date":"2024-02-02","current":10.101698,"twenty":-10.404498,"median":-2.770538,"eighty":-1.887499,"marketCap":107239622},{"date":"2024-02-09","current":10.307855,"twenty":-10.404498,"median":-2.770538,"eighty":-1.878194,"marketCap":109428186},{"date":"2024-02-16","current":10.445293,"twenty":-10.404498,"median":-2.770538,"eighty":-1.865074,"marketCap":110887228},{"date":"2024-02-23","current":9.826821,"twenty":-10.404498,"median":-2.770538,"eighty":-1.859242,"marketCap":104321537},{"date":"2024-03-01","current":11.201202,"twenty":-10.399416,"median":-2.764616,"eighty":-1.84065,"marketCap":118911962},{"date":"2024-03-08","current":10.032979,"twenty":-10.399416,"median":-2.764616,"eighty":-1.815126,"marketCap":106510101},{"date":"2024-03-15","current":12.024111,"twenty":-10.399416,"median":-2.764616,"eighty":-1.798801,"marketCap":99944409},{"date":"2024-03-22","current":11.601155,"twenty":-10.399416,"median":-2.753312,"eighty":-1.765715,"marketCap":96428803},{"date":"2024-03-28","current":10.985943,"twenty":-10.399416,"median":-2.753312,"eighty":-1.731141,"marketCap":91315155},{"date":"2024-04-05","current":10.634392,"twenty":-10.404498,"median":-2.758695,"eighty":-1.704982,"marketCap":88393070},{"date":"2024-04-12","current":10.72228,"twenty":-10.404498,"median":-2.758695,"eighty":-1.630901,"marketCap":89123591},{"date":"2024-04-19","current":9.931292,"twenty":-10.404498,"median":-2.758695,"eighty":-1.553621,"marketCap":82548900},{"date":"2024-04-26","current":10.37073,"twenty":-10.399416,"median":-2.753312,"eighty":-1.502768,"marketCap":86201506},{"date":"2024-05-03","current":10.231792,"twenty":-10.399416,"median":-2.753312,"eighty":-1.45681,"marketCap":85046657},{"date":"2024-05-10","current":11.025638,"twenty":-10.399416,"median":-2.753312,"eighty":-1.426977,"marketCap":91645105},{"date":"2024-05-17","current":12.526258,"twenty":-10.399416,"median":-2.753312,"eighty":-1.393687,"marketCap":85779818},{"date":"2024-05-24","current":12.633321,"twenty":-10.399416,"median":-2.753312,"eighty":-1.35988,"marketCap":86512979},{"date":"2024-05-31","current":12.205072,"twenty":-10.399416,"median":-2.753312,"eighty":-1.337474,"marketCap":83580335},{"date":"2024-06-07","current":12.09801,"twenty":-10.399416,"median":-2.746584,"eighty":-1.32008,"marketCap":82847174},{"date":"2024-06-14","current":12.419196,"twenty":-10.404498,"median":-2.745238,"eighty":-1.307985,"marketCap":85046657},{"date":"2024-06-21","current":12.526258,"twenty":-10.438841,"median":-2.746584,"eighty":-1.281516,"marketCap":85779818},{"date":"2024-06-28","current":13.811003,"twenty":-10.54187,"median":-2.758695,"eighty":-1.257877,"marketCap":94577748},{"date":"2024-07-05","current":11.134452,"twenty":-10.54187,"median":-2.758695,"eighty":-1.2431,"marketCap":76248727},{"date":"2024-07-12","current":12.205072,"twenty":-10.54187,"median":-2.758695,"eighty":-1.222499,"marketCap":83580335},{"date":"2024-07-15","current":12.205072,"twenty":-10.54187,"median":-2.758695,"eighty":-1.212089,"marketCap":83580335},{"date":"2024-08-02","current":11.348576,"twenty":-11.649165,"median":-2.772152,"eighty":-1.193601,"marketCap":77715049},{"date":"2024-08-09","current":11.134452,"twenty":-11.649165,"median":-2.772152,"eighty":-1.178742,"marketCap":76248727},{"date":"2024-08-16","current":-4.754699,"twenty":-11.649165,"median":-2.772152,"eighty":-1.164919,"marketCap":69865540},{"date":"2024-08-23","current":-4.697142,"twenty":-11.649165,"median":-2.793651,"eighty":-1.164919,"marketCap":69019799},{"date":"2024-08-30","current":-4.555001,"twenty":-11.649165,"median":-2.799067,"eighty":-1.164919,"marketCap":66931187},{"date":"2024-09-06","current":-5.105045,"twenty":-11.649165,"median":-2.825981,"eighty":-1.172176,"marketCap":75013527},{"date":"2024-09-13","current":-5.305243,"twenty":-11.649165,"median":-2.832709,"eighty":-1.172176,"marketCap":77955234},{"date":"2024-09-20","current":-5.755688,"twenty":-11.649165,"median":-2.864199,"eighty":-1.172176,"marketCap":84574075},{"date":"2024-09-27","current":-5.355292,"twenty":-11.649165,"median":-2.877542,"eighty":-1.183349,"marketCap":78690661},{"date":"2024-10-04","current":-5.054995,"twenty":-11.649165,"median":-2.919172,"eighty":-1.235399,"marketCap":74278100},{"date":"2024-10-11","current":-5.004946,"twenty":-11.649165,"median":-2.926909,"eighty":-1.318237,"marketCap":73542674},{"date":"2024-10-18","current":-5.455391,"twenty":-11.649165,"median":-2.961811,"eighty":-1.343261,"marketCap":80161514},{"date":"2024-10-25","current":-5.155094,"twenty":-11.649165,"median":-3.006085,"eighty":-1.359997,"marketCap":75748954},{"date":"2024-10-31","current":-5.855787,"twenty":-11.649165,"median":-3.008039,"eighty":-1.398056,"marketCap":86044928},{"date":"2024-11-08","current":-5.805737,"twenty":-11.689082,"median":-3.036417,"eighty":-1.525183,"marketCap":85309501},{"date":"2024-11-15","current":-7.056974,"twenty":-11.689082,"median":-3.072813,"eighty":-1.58483,"marketCap":103695170},{"date":"2024-11-22","current":-12.724521,"twenty":-11.98416,"median":-3.14895,"eighty":-1.643965,"marketCap":122231747},{"date":"2024-11-29","current":-13.184443,"twenty":-12.17163,"median":-3.149928,"eighty":-1.708859,"marketCap":126649762},{"date":"2024-12-06","current":-12.49456,"twenty":-12.366043,"median":-3.229692,"eighty":-1.708859,"marketCap":120022740},{"date":"2024-12-13","current":-13.797673,"twenty":-12.463249,"median":-3.291817,"eighty":-1.71628,"marketCap":132540449},{"date":"2024-12-20","current":-13.337751,"twenty":-12.497966,"median":-3.310435,"eighty":-1.73821,"marketCap":128122434},{"date":"2024-12-27","current":-13.644366,"twenty":-12.532682,"median":-3.320194,"eighty":-1.780748,"marketCap":131067777},{"date":"2025-01-03","current":-15.100787,"twenty":-12.605949,"median":-3.348572,"eighty":-1.788536,"marketCap":145058158},{"date":"2025-01-10","current":-17.400399,"twenty":-12.708302,"median":-3.419516,"eighty":-1.785226,"marketCap":167148233},{"date":"2025-01-17","current":-16.633862,"twenty":-12.808567,"median":-3.52276,"eighty":-1.785226,"marketCap":159784875},{"date":"2025-01-24","current":-19.393396,"twenty":-12.953442,"median":-3.648888,"eighty":-1.785226,"marketCap":186292964},{"date":"2025-01-31","current":-18.24359,"twenty":-13.053431,"median":-3.807696,"eighty":-1.785226,"marketCap":175247927},{"date":"2025-02-07","current":-20.619856,"twenty":-13.179071,"median":-3.887749,"eighty":-1.785226,"marketCap":198074338},{"date":"2025-02-14","current":-20.389895,"twenty":-13.360254,"median":-4.058015,"eighty":-1.785226,"marketCap":195865330},{"date":"2025-02-21","current":-18.626859,"twenty":-13.491058,"median":-4.162726,"eighty":-1.785226,"marketCap":178929606},{"date":"2025-02-28","current":-17.860321,"twenty":-13.571831,"median":-4.258509,"eighty":-1.785226,"marketCap":171566248},{"date":"2025-03-07","current":-18.166936,"twenty":-13.797673,"median":-4.37017,"eighty":-1.781917,"marketCap":174511591},{"date":"2025-03-14","current":-16.633862,"twenty":-14.027634,"median":-4.426926,"eighty":-1.806013,"marketCap":159784875},{"date":"2025-03-21","current":62.809311,"twenty":-14.199078,"median":-4.426926,"eighty":-1.781917,"marketCap":184156900},{"date":"2025-03-28","current":68.664416,"twenty":-14.199078,"median":-4.426926,"eighty":-1.731486,"marketCap":201324069},{"date":"2025-04-04","current":69.196699,"twenty":-14.199078,"median":-4.426926,"eighty":9.414507,"marketCap":202884721},{"date":"2025-04-11","current":61.478605,"twenty":-14.164789,"median":-4.426926,"eighty":9.60692,"marketCap":180255271},{"date":"2025-04-17","current":69.196699,"twenty":-14.164789,"median":-4.37017,"eighty":9.758102,"marketCap":202884721},{"date":"2025-04-25","current":78.245498,"twenty":-14.199078,"median":-4.058015,"eighty":9.826821,"marketCap":229415799},{"date":"2025-05-02","current":79.842345,"twenty":-14.199078,"median":-3.731273,"eighty":9.895541,"marketCap":234097755},{"date":"2025-05-09","current":76.914792,"twenty":-14.199078,"median":-3.62153,"eighty":10.01918,"marketCap":225514170},{"date":"2025-05-16","current":34.018394,"twenty":-14.199078,"median":-3.44594,"eighty":10.055382,"marketCap":132943882},{"date":"2025-05-23","current":33.610987,"twenty":-14.199078,"median":-3.37695,"eighty":10.101698,"marketCap":131351739},{"date":"2025-05-30","current":32.38877,"twenty":-14.199078,"median":-3.34545,"eighty":10.107067,"marketCap":126575312},{"date":"2025-06-06","current":30.962849,"twenty":-14.199078,"median":-3.320194,"eighty":10.170417,"marketCap":121002814},{"date":"2025-06-13","current":31.370255,"twenty":-14.199078,"median":-3.291817,"eighty":10.239136,"marketCap":122594957},{"date":"2025-06-20","current":28.518414,"twenty":-14.027634,"median":-3.241732,"eighty":10.37073,"marketCap":111449961},{"date":"2025-06-27","current":29.536928,"twenty":-13.848978,"median":-3.190184,"eighty":10.376574,"marketCap":115430316},{"date":"2025-07-03","current":31.370255,"twenty":-13.848978,"median":-3.149439,"eighty":10.459037,"marketCap":122594957},{"date":"2025-07-11","current":30.148037,"twenty":-13.848978,"median":-3.108336,"eighty":10.583107,"marketCap":117818530},{"date":"2025-07-18","current":30.555443,"twenty":-13.848978,"median":-3.054751,"eighty":10.65145,"marketCap":119410672},{"date":"2025-07-25","current":31.573958,"twenty":-13.848978,"median":-3.021648,"eighty":10.720591,"marketCap":123391028},{"date":"2025-08-01","current":29.740631,"twenty":-13.848978,"median":-3.006967,"eighty":10.793764,"marketCap":116226387},{"date":"2025-08-08","current":30.759146,"twenty":-13.848978,"median":-2.971366,"eighty":10.903709,"marketCap":120206743},{"date":"2025-08-15","current":19.313596,"twenty":-13.644366,"median":-2.937379,"eighty":11.065777,"marketCap":121192814},{"date":"2025-08-22","current":20.075975,"twenty":-13.429736,"median":-2.919172,"eighty":11.134452,"marketCap":125976741},{"date":"2025-08-29","current":19.694785,"twenty":-13.123121,"median":-2.8825,"eighty":11.169615,"marketCap":123584778},{"date":"2025-09-05","current":20.203038,"twenty":-12.90849,"median":-2.875275,"eighty":11.241514,"marketCap":126774062},{"date":"2025-09-12","current":22.108985,"twenty":-12.628566,"median":-2.846166,"eighty":11.42538,"marketCap":138733880},{"date":"2025-09-19","current":23.633742,"twenty":-12.250828,"median":-2.825981,"eighty":11.601155,"marketCap":148301733},{"date":"2025-09-26","current":25.920879,"twenty":-10.604625,"median":-2.799067,"eighty":11.743105,"marketCap":162653514},{"date":"2025-10-03","current":29.732773,"twenty":-10.114998,"median":-2.793273,"eighty":11.832516,"marketCap":186573149},{"date":"2025-10-10","current":32.528162,"twenty":-9.805062,"median":-2.772152,"eighty":11.957111,"marketCap":204114214},{"date":"2025-10-17","current":30.495152,"twenty":-9.762245,"median":-2.772018,"eighty":11.990948,"marketCap":191357076}],"updateTime":1760809480790},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PLX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2576505793","title":"Why Is Protalix BioTherapeutics Stock Falling On Friday?","url":"https://stock-news.laohu8.com/highlight/detail?id=2576505793","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576505793?lang=en_us&edition=fundamental","pubTime":"2025-10-17 23:23","pubTimestamp":1760714580,"startTime":"0","endTime":"0","summary":"EMA issues a negative opinion on Protalix and Chiesi's Elfabrio revised dosing for Fabry disease, citing insufficient data to confirm efficacy.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/10/17/Medicine-And-Health-Concept--On-A-White-.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/10/17/Medicine-And-Health-Concept--On-A-White-.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/health-care/25/10/48278076/why-is-protalix-biotherapeutics-stock-falling-on-friday","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/25/10/48278076/why-is-protalix-biotherapeutics-stock-falling-on-friday","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["LU0109394709.USD","QURE","PLX","BK4087","LU0889565916.HKD","EMA","CHMP","BK4139","BK4081","LU0320765992.SGD"],"gpt_icon":0},{"id":"2576105304","title":"Protalix Shares Sink After EMA Rejects Once-Monthly Treatment Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2576105304","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576105304?lang=en_us&edition=fundamental","pubTime":"2025-10-17 21:28","pubTimestamp":1760707680,"startTime":"0","endTime":"0","summary":"Shares of Protalix BioTherapeutics fell after the company said the European Medicines Agency rejected its request to approve a once-every-four-weeks dosing schedule for its Fabry disease treatment, Elfabrio.The stock tumbled 30% to $1.67 in premarket trading Friday. Through Thursday's close, shares are up 28% so far this year.The Israel-based company, which developed Elfabrio alongside Chiesi Global Rare Diseases, part of Italy-based Chiesi Group, had been seeking approval for a new, less frequent dosing regimen for Elfabrio. The treatment is currently approved at a lower dose, once every two weeks.Protalix and Chiesi submitted data from a recent study testing the monthly dosing in patients who had already been using the drug. However, the agency's Committee for Medicinal Products for Human Use concluded that data wasn't strong enough to prove it had the same efficacy as that of the currently approved schedule, the companies said on Friday.\"We are disappointed by the result of this rev","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4081","BK4139","EMA","PLX"],"gpt_icon":0},{"id":"2576375270","title":"Protalix BioTherapeutics Highlights Rare Disease Drug Pipeline and New Gout Therapy in Latest Corporate Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2576375270","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576375270?lang=en_us&edition=fundamental","pubTime":"2025-10-17 20:09","pubTimestamp":1760702997,"startTime":"0","endTime":"0","summary":"Protalix BioTherapeutics Inc. has released a corporate presentation detailing its current pipeline and financial status. The company reported $53 million in revenue for the full year 2024 and $25.4 million in revenue from product sales in the first half of 2025. As of June 30, 2025, Protalix holds $33.4 million in cash with no debt or warrants, supporting its operations and pipeline development into 2027. Protalix highlighted its commercial portfolio, which includes approved enzyme replacement therapies for Fabry disease and Gaucher disease in the United States, European Union, and additional markets. The development portfolio features PRX-115, a PEGylated uricase candidate targeting uncontrolled gout, with a Phase 2 trial expected to begin in the fourth quarter of 2025. The company is also advancing PRX-119, a long-acting DNase I, and is pursuing additional programs in rare renal and NETs-related diseases. Over the next three years, Protalix aims to expand its pipeline to five to seve","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251017:nNDL1vNnGB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLX","BK4139"],"gpt_icon":0},{"id":"2568746873","title":"Barclays Remains a Hold on PLUXEE N.V. (PLX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2568746873","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568746873?lang=en_us&edition=fundamental","pubTime":"2025-09-17 15:05","pubTimestamp":1758092748,"startTime":"0","endTime":"0","summary":"Barclays analyst Pravin Gondhale maintained a Hold rating on PLUXEE N.V. today and set a price target of €21.00. The company’s shares closed yester...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/barclays-remains-a-hold-on-pluxee-n-v-plx-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/barclays-remains-a-hold-on-pluxee-n-v-plx-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","PLX"],"gpt_icon":0},{"id":"2567489461","title":"3 Penny Stocks With Market Caps Over $30M To Consider","url":"https://stock-news.laohu8.com/highlight/detail?id=2567489461","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567489461?lang=en_us&edition=fundamental","pubTime":"2025-09-16 19:05","pubTimestamp":1758020705,"startTime":"0","endTime":"0","summary":"As the Nasdaq and S&P 500 reach record highs, investors are keenly watching the Federal Reserve's upcoming interest rate decision, which could influence market dynamics. Penny stocks may be a throwback term, but the opportunities they represent are far from old news. Typically referring to smaller or newer companies, these stocks present an underappreciated chance for growth at lower price points.","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9021000-choice2-main-header/1585186684476","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9021000-choice2-main-header/1585186684476"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/telecom/otc-vplm/voip-palcom/news/3-penny-stocks-with-market-caps-over-30m-to-consider-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/telecom/otc-vplm/voip-palcom/news/3-penny-stocks-with-market-caps-over-30m-to-consider-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["PBYI","TTI","BK4089","BK4021","LCUT","WDH","BK4023","BK4173","BK4180","RERE","BK7090","BK4076","BK4539","VPLM","BK4509","BABB","TBTC","TTI.AU","BK4122","BK4179","MAPS","BK4551","BK4209","BK4150","BK4503","BK4113","BK4139","DDL","PSHG","PLX"],"gpt_icon":0},{"id":"2567106260","title":"PLUXEE N.V. (PLX) was downgraded to a Hold Rating at Bernstein","url":"https://stock-news.laohu8.com/highlight/detail?id=2567106260","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567106260?lang=en_us&edition=fundamental","pubTime":"2025-09-16 17:55","pubTimestamp":1758016532,"startTime":"0","endTime":"0","summary":"In a report released today, Sabrina Blanc from Bernstein downgraded PLUXEE N.V. to a Hold, with a price target of €17.50. The company’s shares clos...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/pluxee-n-v-plx-was-downgraded-to-a-hold-rating-at-bernstein-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/pluxee-n-v-plx-was-downgraded-to-a-hold-rating-at-bernstein-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PLX"],"gpt_icon":0},{"id":"2566992635","title":"Protalix BioTherapeutics Inc. to Present at the Upcoming Investor Summit Virtual Event","url":"https://stock-news.laohu8.com/highlight/detail?id=2566992635","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566992635?lang=en_us&edition=fundamental","pubTime":"2025-09-11 22:55","pubTimestamp":1757602518,"startTime":"0","endTime":"0","summary":"Protalix BioTherapeutics Inc. will be presenting at the Q3 Investor Summit Virtual on September 16, 2025. Eyal Rubin, the company's former Senior Vice President and Chief Financial Officer, will update investors on Protalix's growth strategies and market opportunities.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Protalix BioTherapeutics Inc. published the original content used to generate this news brief via ACCESS Newswire  on September 11, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250911:nNDL4bYXmv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLX","BK4139"],"gpt_icon":0},{"id":"2564067408","title":"Protalix BioTherapeutics Inc. to Present at H.C. Wainwright 27th Annual Global Investment Conference in New York City","url":"https://stock-news.laohu8.com/highlight/detail?id=2564067408","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564067408?lang=en_us&edition=fundamental","pubTime":"2025-09-02 18:50","pubTimestamp":1756810215,"startTime":"0","endTime":"0","summary":"Protalix BioTherapeutics Inc., a biopharmaceutical company specializing in recombinant therapeutic proteins, will be presenting at the H.C. Wainwright 27th Annual Global Investment Conference from September 8-10, 2025. Dror Bashan, the company's President and CEO, is scheduled to present on September 8 at 3:30 p.m. EDT in New York City.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Protalix BioTherapeutics Inc. published the original content used to generate this news brief via PR Newswire  on September 02, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250902:nNDL8nQ5D1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLX","BK4139"],"gpt_icon":0},{"id":"2564890870","title":"Protalix BioTherapeutics Inc. Releases Presentation Highlighting Expansion into Rare Disease Space and Commercialization of Elfabrio®","url":"https://stock-news.laohu8.com/highlight/detail?id=2564890870","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564890870?lang=en_us&edition=fundamental","pubTime":"2025-09-01 16:33","pubTimestamp":1756715608,"startTime":"0","endTime":"0","summary":"Protalix BioTherapeutics Inc. Releases Presentation Highlighting Expansion into Rare Disease Space and Commercialization of Elfabrio. Protalix BioTherapeutics Inc. has released a corporate presentation highlighting its established commercial foundation and ongoing expansion into the rare disease space. The presentation details the commercialization of Elfabrio , a product approved for the treatment of adult patients with Fabry disease. The document discusses various aspects of Elfabrio, including its revenue, expenses, market acceptance, competition, and regulatory considerations. The presentation also touches upon the regulatory approval and commercial prospects of other products and product candidates within the company's portfolio. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250901:nNDL1bw43Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PLX"],"gpt_icon":0},{"id":"2562220622","title":"Protalix BioTherapeutics Inc. Files Initial Beneficial Ownership Statement for Gilad Mamlok, Sr. VP and CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2562220622","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562220622?lang=en_us&edition=fundamental","pubTime":"2025-08-26 04:32","pubTimestamp":1756153937,"startTime":"0","endTime":"0","summary":"Protalix BioTherapeutics Inc. has filed an initial statement of beneficial ownership. The filing mentions Gilad Mamlok as the beneficial owner, who serves as the Senior Vice President and Chief Financial Officer  of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Protalix BioTherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 25, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250825:nNDLcc6hky:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PLX"],"gpt_icon":0},{"id":"2559596899","title":"Protalix BioTherapeutics Q2 Sales $15.658M Beat $13.546M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2559596899","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559596899?lang=en_us&edition=fundamental","pubTime":"2025-08-14 18:51","pubTimestamp":1755168713,"startTime":"0","endTime":"0","summary":"Protalix BioTherapeutics (AMEX:PLX) reported quarterly sales of $15.658 million which beat the analyst consensus estimate of $13.546 million by 15.59 percent.  This is a 16.21 percent increase over sales of $13.474","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/08/47117287/protalix-biotherapeutics-q2-sales-15-658m-beat-13-546m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLX"],"gpt_icon":0},{"id":"2559959633","title":"Protalix BioTherapeutics Reports 16% Revenue Increase in Q2 2025, Achieves Net Income of $164K, EPS at $0.00","url":"https://stock-news.laohu8.com/highlight/detail?id=2559959633","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559959633?lang=en_us&edition=fundamental","pubTime":"2025-08-14 18:51","pubTimestamp":1755168660,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Protalix BioTherapeutics Inc. published the original content used to generate this news brief via PR Newswire  on August 14, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250814:nNDL6jdnpb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLX"],"gpt_icon":1},{"id":"2559621250","title":"Director Aharon Schwartz Reports Acquisition of Protalix BioTherapeutics Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2559621250","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559621250?lang=en_us&edition=fundamental","pubTime":"2025-08-13 04:30","pubTimestamp":1755030641,"startTime":"0","endTime":"0","summary":"Aharon Schwartz, a Director of Protalix BioTherapeutics Inc., reported an acquisition of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Protalix BioTherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 12, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250812:nNDLxvqHC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Director Aharon Schwartz Reports Acquisition of Protalix BioTherapeutics Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PLX"],"gpt_icon":0},{"id":"2557560129","title":"Protalix BioTherapeutics Inc. to Release Second Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2557560129","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557560129?lang=en_us&edition=fundamental","pubTime":"2025-08-08 00:53","pubTimestamp":1754585616,"startTime":"0","endTime":"0","summary":"On August 14, 2025, Protalix BioTherapeutics Inc. will announce its second quarter financial results. The results will be released on the Protalix website, and a conference call to present the results will be hosted. The webcast can be accessed at the following URLs: Company Link and Webcast Link. Management will attend the call.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Protalix BioTherapeutics Inc. published the original content used to generate this news brief via PR Newswire  on August 07, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250807:nNDL4Xf0J9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PLX"],"gpt_icon":0},{"id":"2553475207","title":"Protalix BioTherapeutics Appoints Gilad Mamlok as New CFO, Succeeding Eyal Rubin","url":"https://stock-news.laohu8.com/highlight/detail?id=2553475207","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553475207?lang=en_us&edition=fundamental","pubTime":"2025-07-21 18:50","pubTimestamp":1753095038,"startTime":"0","endTime":"0","summary":"Protalix BioTherapeutics Inc. has appointed Gilad Mamlok as its new Senior Vice President and Chief Financial Officer, effective August 24, 2025. Mamlok succeeds Eyal Rubin and brings three decades of experience in healthcare and technology companies. Rubin will remain available to the company until October 2025 to assist with the transition.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Protalix BioTherapeutics Inc. published the original content used to generate this news brief via PR Newswire  on July 21, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250721:nNDL704K62:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PLX"],"gpt_icon":0},{"id":"2548387138","title":"Protalix BioTherapeutics Inc. Files Initial Statement of Beneficial Ownership for Director Elze Christian","url":"https://stock-news.laohu8.com/highlight/detail?id=2548387138","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548387138?lang=en_us&edition=fundamental","pubTime":"2025-07-04 04:31","pubTimestamp":1751574662,"startTime":"0","endTime":"0","summary":"Protalix BioTherapeutics Inc. has filed an initial statement of beneficial ownership. The filing lists Elze Christian as a director of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Protalix BioTherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on July 03, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250703:nNDL532J3N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PLX"],"gpt_icon":0},{"id":"2547093693","title":"Protalix BioTherapeutics Joins Russell 3000 and 2000 Indexes","url":"https://stock-news.laohu8.com/highlight/detail?id=2547093693","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547093693?lang=en_us&edition=fundamental","pubTime":"2025-06-30 18:50","pubTimestamp":1751280617,"startTime":"0","endTime":"0","summary":"Protalix BioTherapeutics Inc. has been added to the Russell 3000 and Russell 2000 Indexes, effective as of the U.S. market close on June 27, 2025. This inclusion follows the annual reconstitution of the Russell indexes, which captures the 4,000 largest US stocks based on market capitalization as of April 30.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Protalix BioTherapeutics Inc. published the original content used to generate this news brief via PR Newswire  on June 30, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250630:nNDLKG2l3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PLX"],"gpt_icon":0},{"id":"2546759290","title":"Protalix BioTherapeutics Inc. Convened Annual Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2546759290","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546759290?lang=en_us&edition=fundamental","pubTime":"2025-06-27 04:31","pubTimestamp":1750969864,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Protalix BioTherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 26, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250626:nNDL7V5h87:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLX","BK4139"],"gpt_icon":0},{"id":"2535902635","title":"Protalix BioTherapeutics Inc. Unveils Corporate Presentation Highlighting Expansion in Rare Disease Space","url":"https://stock-news.laohu8.com/highlight/detail?id=2535902635","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535902635?lang=en_us&edition=fundamental","pubTime":"2025-05-14 20:07","pubTimestamp":1747224443,"startTime":"0","endTime":"0","summary":"Protalix BioTherapeutics Inc. recently released a corporate presentation highlighting its strategic initiatives and commercial portfolio in the rare disease space. The presentation provides an overview of their established commercial foundation, which supports further expansion efforts. Among the key products mentioned is Elelyso , an FDA-approved treatment that is commercially marketed. The presentation also discusses the commercialization aspects of Elfabrio , a product approved for the treatment of adult patients with Fabry disease. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Protalix BioTherapeutics Inc. published the original content used to generate this news brief o","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nNDLbPSCzz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLX","BK4139"],"gpt_icon":0},{"id":"2535442240","title":"Protalix BioTherapeutics Inc. to Present at H.C. Wainwright BioConnect Investor Conference in NYC","url":"https://stock-news.laohu8.com/highlight/detail?id=2535442240","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535442240?lang=en_us&edition=fundamental","pubTime":"2025-05-14 18:50","pubTimestamp":1747219833,"startTime":"0","endTime":"0","summary":"Protalix BioTherapeutics Inc., a biopharmaceutical company focused on recombinant therapeutic proteins, will participate in the 3rd Annual H.C. Wainwright BioConnect Investor Conference on May 20, 2025, at the Nasdaq headquarters in New York City. Eyal Rubin, the company's Sr. Vice President and Chief Financial Officer, will deliver a company presentation and be available for one-on-one investor meetings throughout the event.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Protalix BioTherapeutics Inc. published the original content used to generate this news brief via PR Newswire  on May 14, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nNDL1MPZlX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PLX"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":23,"code":"91000000","status":"200"}]}}